EGFR and cancer: Among the four cancer driver genes, MGPs predicted for IDH1 mutant showed the highest literature coverage (80.4%; 45 out of the 56 predicted MGPs supported by previous studies), followed by TP53 mutant (78.6%; 11 out of the 14 MGPs supported), CIC mutant (48.1%; 13 out of the 27 MGPs supported), and EGFR mutant (55.6%; 10 out of the 18 MGPs supported).